| Literature DB >> 18715502 |
Hanne Nørgaard Heje1, Peter Vedsted, Ineta Sokolowski, Frede Olesen.
Abstract
BACKGROUND: Knowledge of the extent to which patient characteristics are systematically associated with variation in patient evaluations will enable us to adjust for differences between practice populations and thereby compare GPs. Whether this is appropriate depends on the purpose for which the patient evaluation was conducted. Associations between evaluations and patient characteristics may reflect gaps in the quality of care or may be due to inherent characteristics of the patients. This study aimed to determine such associations in a setting with a comprehensive list system and gate-keeping.Entities:
Mesh:
Year: 2008 PMID: 18715502 PMCID: PMC2533311 DOI: 10.1186/1472-6963-8-178
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Distribution of characteristics among participating patients.
| N = 27313 | Female | 18985 | 69.5 |
| Male | 8328 | 30.5 | |
| N = 27379 | 18–24 | 1284 | 4.7 |
| 25–29 | 2296 | 8.4 | |
| 30–34 | 3060 | 11.2 | |
| 35–39 | 2872 | 10.5 | |
| 40–44 | 2392 | 8.7 | |
| 45–49 | 1988 | 7.3 | |
| 50–54 | 2169 | 7.9 | |
| 55–59 | 2376 | 8.7 | |
| 60–64 | 2109 | 7.7 | |
| 65–69 | 1945 | 7.1 | |
| 70–74 | 1813 | 6.6 | |
| 75–79 | 1551 | 5.7 | |
| 80+ | 1524 | 5.6 | |
| N = 25870 | None | 4766 | 18.4 |
| Less than 2 | 2019 | 7.8 | |
| 2–4 | 14094 | 54.5 | |
| 5 or more | 3591 | 13.9 | |
| Undergoing education or other | 1400 | 5.4 | |
| N = 25860 | 0–1 | 2434 | 9.4 |
| 2–3 | 7848 | 30.4 | |
| 4–5 | 6535 | 25.3 | |
| 6–7 | 3534 | 13.7 | |
| 8–9 | 1840 | 7.1 | |
| 10+ | 3669 | 14.2 | |
| N = 18134 | Less than 1 | 1431 | 7.9 |
| 1–2 | 2065 | 11.4 | |
| 3–7 | 5600 | 30.9 | |
| 8–12 | 3962 | 21.9 | |
| 13+ | 5076 | 28.0 | |
| N = 27087 | Excellent | 2350 | 8.7 |
| Very good | 8121 | 30.0 | |
| Good | 10488 | 38.7 | |
| Fair | 5141 | 19.0 | |
| Poor | 987 | 3.6 | |
| N = 26801 | No | 13703 | 51.1 |
| Yes-KRTC1 | 4509 | 16.8 | |
| Yes-other or multiple | 8589 | 32.1 | |
| N = 182122 | None | 13703 | 72.1 |
| K – Cardiovascular | 2029 | 10.7 | |
| R – Respiratory | 1095 | 5.8 | |
| T – Endocrine | 1085 | 5.7 | |
| C – Cancer | 300 | 1.6 | |
1 Reported conditions categorised according to ICPC-2 main categories: K, R and T and the ad hoc-category C (cancer).
2 Patients reporting no chronic condition or reporting KRTC-conditions.
Dimension 1: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the doctor-patient relationship.
| (N = 25533) | Female | 63.8 | 1 | 1 | 14.9 | 1 | 1 | ||
| Male | 65.1 | 1.02 | 0.98 | 0.96 – 1.00 | 13.0 | 0.93 | 0.86 – 1.00 | ||
| (N = 25533) | 18–24 | 52.3 | 1 | 1 | 16.4 | 1 | 1 | ||
| 25–29 | 54.3 | 1.04 | 1.03 | 0.96 – 1.10 | 16.6 | 1.03 | 1.03 | 0.87 – 1.22 | |
| 30–34 | 57.6 | 16.7 | 1.00 | 0.99 | 0.86 – 1.15 | ||||
| 35–39 | 58.8 | 17.0 | 1.01 | 0.96 | 0.82 – 1.13 | ||||
| 40–44 | 60.1 | 17.3 | 1.00 | 0.93 | 0.80 – 1.09 | ||||
| 45–49 | 61.2 | 16.1 | |||||||
| 50–54 | 65.2 | 14.2 | |||||||
| 55–59 | 67.6 | 13.0 | |||||||
| 60–64 | 70.2 | 11.8 | |||||||
| 65–69 | 76.8 | 9.4 | |||||||
| 70–74 | 76.7 | 10.5 | |||||||
| 75–79 | 73.6 | 11.2 | |||||||
| 80+ | 72.8 | 10.4 | |||||||
| (N = 24364) | None | 66.3 | 13 | 13 | 13.3 | 1 | 1 | ||
| Less than 2 | 64.5 | 1.01 | 0.97 – 1.05 | 14.8 | 1.12 | 1.05 | 0.92 – 1.19 | ||
| 2–4 | 63.8 | 0.99 | 0.96 – 1.02 | 14.6 | 1.10 | 1.07 | 0.98 – 1.17 | ||
| 5 or more | 62.2 | 0.96 | 0.93 – 1.00 | 14.7 | 1.10 | 1.11 | 0.99 – 1.25 | ||
| Undergoing education or other | |||||||||
| 66.0 | 12.4 | 0.94 | 0.91 | 0.76 – 1.08 | |||||
| (N = 25533) | 0–1 | 60.7 | 1 | 1 | 16.4 | 1 | 1 | ||
| 2–3 | 61.9 | 1.02 | 1.04 | 1.00 – 1.07 | 15.7 | 0.95 | 0.91 | 0.82 – 1.01 | |
| 4–5 | 64.6 | 14.1 | |||||||
| 6–7 | 65.1 | 14.1 | |||||||
| 8–9 | 67.5 | 13.0 | |||||||
| 10+ | 68.2 | 11.4 | |||||||
| (N = 16985) | Less than 1 | 63.2 | 1 | 1 | 16.5 | 1 | 1 | ||
| 1–2 | 64.6 | 1.02 | 1.00 | 0.95 – 1.05 | 13.6 | 0.89 | 0.75 – 1.05 | ||
| 3–7 | 64.6 | 1.02 | 0.98 | 0.94 – 1.02 | 13.7 | 0.92 | 0.80 – 1.07 | ||
| 8–12 | 65.5 | 1.04 | 0.97 | 0.92 – 1.02 | 13.4 | 0.93 | 0.80 – 1.08 | ||
| 13+ | 68.3 | 1.00 | 0.95 – 1.05 | 11.9 | |||||
| (N = 25533) | Excellent | 67.6 | 1 | 1 | 12.0 | 1 | 1 | ||
| Very good | 64.5 | 12.5 | 1.04 | ||||||
| Good | 65.0 | 14.6 | |||||||
| Fair | 61.4 | 17.2 | |||||||
| Poor | 58.2 | 18.6 | |||||||
| (N = 25170 | No | 62.3 | 1 | 13 | 14.8 | 1 | 1 | ||
| Yes-KRTC | 70.6 | 12.2 | |||||||
| Yes-other or multiple | 63.9 | 1.03 | 14.7 | 0.99 | |||||
| (N = 17192) | None | 62.3 | 1 | 13 | 14.8 | 1 | 1 | ||
| K – Cardiovascular | 72.1 | 10.7 | 0.85 | 0.73 – 1.00 | |||||
| R – Respiratory | 66.5 | 14.9 | 1.01 | 0.99 | 0.85 – 1.15 | ||||
| T – Endocrine | 69.8 | 1.04 | 1.00 – 1.09 | 13.7 | 0.93 | 1.01 | 0.85 – 1.20 | ||
| C – Cancer | 77.7 | 6.6 | |||||||
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self-rated health and clustering of frequency patients. Numbers in italics are used to indicate statistical significance.
1 Patients who marked 100% of the answered questions in one of the two most positive answering categories.
2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories.
3 Poisson regression with robust variance
Dimension 2: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the medical care.
| (N = 25377) | Female | 61.2 | 1 | 13 | 19.4 | 1 | 1 | ||
| Male | 61.2 | 1.00 | 19.2 | 0.99 | 1.06 | 1.00 – 1.13 | |||
| (N = 25377) | 18–24 | 47.8 | 1 | 13 | 26.2 | 1 | 1 | ||
| 25–29 | 52.3 | 1.07 | 0.99 – 1.16 | 23.2 | 1.03 | 0.92 | 0.82 – 1.04 | ||
| 30–34 | 56.8 | 21.6 | 1.00 | ||||||
| 35–39 | 56.3 | 21.8 | 1.01 | ||||||
| 40–44 | 57.7 | 20.9 | 1.00 | ||||||
| 45–49 | 57.5 | 21.9 | |||||||
| 50–54 | 61.1 | 19.0 | |||||||
| 55–59 | 64.5 | 17.9 | |||||||
| 60–64 | 67.1 | 15.6 | |||||||
| 65–69 | 73.0 | 13.1 | |||||||
| 70–74 | 71.4 | 14.9 | |||||||
| 75–79 | 70.1 | 14.8 | |||||||
| 80+ | 69.8 | 15.6 | |||||||
| (N = 24220) | None | 60.2 | 1 | 13 | 19.6 | 1 | 1 | ||
| Less than 2 | 60.4 | 1.01 | 1.03 | 0.99 – 1.07 | 20.8 | 1.06 | 1.04 | 0.94 – 1.16 | |
| 2–4 | 61.5 | 0.91 | 1.02 | 0.99 – 1.05 | 19.1 | 0.97 | 1.02 | 0.95 – 1.10 | |
| 5 or more | 61.2 | 0.80 | 1.00 | 0.97 – 1.04 | 18.8 | 0.96 | 1.03 | 0.93 – 1.14 | |
| Undergoing education or other | 61.4 | 0.90 | 17.3 | 0.88 | |||||
| (N = 25377) | 0–1 | 64.2 | 1 | 13 | 19.0 | 1 | 1 | ||
| 2–3 | 60.9 | 0.98 | 0.95 – 1.01 | 19.2 | 1.01 | 0.96 | 0.88 – 1.05 | ||
| 4–5 | 61.9 | 0.96 | 1.01 | 0.98 – 1.05 | 19.3 | 1.02 | 0.92 | 0.84 – 1.01 | |
| 6–7 | 60.0 | 1.01 | 0.98 – 1.06 | 19.3 | 1.02 | ||||
| 8–9 | 60.6 | 1.04 | 1.00 – 1.09 | 19.5 | 1.03 | ||||
| 10+ | 60.1 | 19.8 | 1.04 | ||||||
| (N = 16880) | Less than 1 | 60.5 | 1 | 13 | 20.3 | 1 | 1 | ||
| 1–2 | 62.7 | 1.04 | 1.01 | 0.96 – 1.07 | 18.4 | 0.91 | 0.99 | 0.86 – 1.12 | |
| 3–7 | 61.2 | 1.01 | 0.96 | 0.91 – 1.01 | 19.0 | 0.93 | 1.05 | 0.93 – 1.18 | |
| 8–12 | 62.4 | 1.03 | 0.96 | 0.90 – 1.01 | 19.1 | 0.94 | 1.11 | 0.98 – 1.27 | |
| 13+ | 65.8 | 1.00 | 0.94 – 1.06 | 16.0 | 0.94 | 0.83 – 1.08 | |||
| (N = 25377) | Excellent | 71.8 | 1 | 13 | 13.4 | 1 | 1 | ||
| Very good | 64.8 | 15.7 | |||||||
| Good | 61.1 | 19.2 | |||||||
| Fair | 52.4 | 26.5 | |||||||
| Poor | 48.2 | 30.2 | |||||||
| (N = 25017) | No | 64.6 | 1 | 13 | 18.6 | 1 | 1 | ||
| Yes-KRTC | 67.9 | 15.9 | |||||||
| Yes-other or multiple | 57.1 | 1.01 | 0.98 – 1.04 | 22.2 | 0.96 | 0.90 – 1.02 | |||
| (N = 17058) | 61.6 | 1 | 13 | 18.6 | 1 | 1 | |||
| K – Cardiovascular | 70.6 | 13.7 | |||||||
| R – Respiratory | 60.6 | 0.98 | 1.05 | 0.99 – 1.10 | 19.4 | 1.04 | 0.90 | 0.79 – 1.04 | |
| T – Endocrine | 68.2 | 17.9 | 0.96 | 0.94 | 0.81 – 1.08 | ||||
| C – Cancer | 75.2 | 11.7 | |||||||
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self -rated health and clustering of frequency patients. Numbers in italics are used to indicate statistical significance.
1 Patients who marked 100% of the answered questions in one of the two most positive answering categories.
2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories.
3 Poisson regression with robust variance
Dimension 3: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the information and support.
| (N = 25154) | Female | 64.5 | 1 | 13 | 19.7 | 1 | 1 | ||
| Male | 64.4 | 1.00 | 19.1 | 0.97 | 1.05 | 0.99 – 1.11 | |||
| (N = 25154) | 18–24 | 52.4 | 1 | 13 | 25.0 | 1 | 1 | ||
| 25–29 | 55.5 | 1.06 | 1.04 | 0.97 – 1.12 | 23.7 | 1.03 | 0.96 | 0.84 – 1.10 | |
| 30–34 | 57.8 | 22.9 | 1.00 | 0.90 | 0.79 – 1.02 | ||||
| 35–39 | 60.2 | 22.5 | 1.01 | ||||||
| 40–44 | 61.0 | 22.6 | 1.00 | ||||||
| 45–49 | 62.1 | 21.1 | |||||||
| 50–54 | 63.9 | 18.8 | |||||||
| 55–59 | 68.8 | 17.2 | |||||||
| 60–64 | 70.9 | 16.2 | |||||||
| 65–69 | 75.1 | 13.1 | |||||||
| 70–74 | 75.6 | 14.4 | |||||||
| 75–79 | 71.7 | 15.1 | |||||||
| 80+ | 73.7 | 14.2 | |||||||
| (N = 24003) | None | 65.9 | 1 | 13 | 19.1 | 1 | 1 | ||
| Less than 2 | 65.1 | 1.02 | 0.98 – 1.06 | 20.6 | 1.08 | 1.03 | 0.92 – 1.15 | ||
| 2–4 | 64.1 | 0.99 | 0.96 – 1.01 | 19.5 | 1.02 | 1.01 | 0.93 – 1.08 | ||
| 5 or more | 63.5 | 0.97 | 0.94 – 1.01 | 19.4 | 1.01 | 1.01 | 0.92 – 1.11 | ||
| Undergoing education or other | 63.9 | 1.02 | 0.97 – 1.07 | 18.7 | 0.97 | 0.91 | 0.79 – 1.06 | ||
| (N = 25154) | 0–1 | 63.9 | 1 | 13 | 22.5 | 1 | 1 | ||
| 2–3 | 63.1 | 0.99 | 1.01 | 0.98 – 1.05 | 20.8 | 0.93 | |||
| 4–5 | 63.8 | 1.00 | 1.03 | 1.00 – 1.07 | 18.9 | ||||
| 6–7 | 65.7 | 1.03 | 19.4 | ||||||
| 8–9 | 66.0 | 1.03 | 18.5 | ||||||
| 10+ | 66.6 | 1.04 | 16.5 | ||||||
| (N = 16745) | Less than 1 | 63.9 | 1 | 13 | 20.2 | 1 | 1 | ||
| 1–2 | 65.4 | 1.02 | 0.99 | 0.94 – 1.05 | 18.8 | 0.93 | 1.01 | 0.88 – 1.17 | |
| 3–7 | 65.0 | 1.02 | 0.97 | 0.92 – 1.01 | 18.5 | 0.91 | 1.02 | 0.90 – 1.16 | |
| 8–12 | 66.0 | 1.03 | 0.96 | 0.91 – 1.01 | 18.2 | 0.90 | 1.05 | 0.91 – 1.21 | |
| 13+ | 68.2 | 0.98 | 0.93 – 1.03 | 17.0 | 1.01 | 0.88 – 1.16 | |||
| (N = 25154) | Excellent | 71.2 | 1 | 13 | 15.7 | 1 | 1 | ||
| Very good | 66.9 | 17.2 | 1.10 | ||||||
| Good | 64.5 | 19.7 | |||||||
| Fair | 58.8 | 23.4 | |||||||
| Poor | 55.8 | 26.5 | |||||||
| (N = 24795) | No | 63.7 | 1 | 13 | 20.2 | 1 | 1 | ||
| Yes-KRTC | 70.9 | 15.5 | |||||||
| Yes-other or multiple | 62.1 | 0.98 | 1.02 | 0.99 – 1.04 | 20.6 | 1.02 | |||
| (N = 16860) | None | 63.7 | 1 | 13 | 20.2 | 1 | 1 | ||
| K – Cardiovascular | 73.0 | 14.3 | |||||||
| R – Respiratory | 65.5 | 1.03 | 19.5 | 0.97 | 0.91 | 0.79 – 1.04 | |||
| T – Endocrine | 70.7 | 15.0 | |||||||
| C – Cancer | 76.8 | 11.1 | |||||||
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self -rated health and clustering of frequency patients. Numbers in italics are used to indicate statistical significance.
1 Patients who marked 100% of the answered questions in one of the two most positive answering categories.
2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories.
3 Poisson regression with robust variance
Dimension 4: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the organisation of care.
| (N = 24154) | Female | 64.5 | 1 | 13 | 23.4 | 1 | 1 | ||
| Male | 68.3 | 1.01 | 0.99 – 1.03 | ||||||
| (N = 24154) | 18–24 | 58.4 | 1 | 13 | 28.1 | 1 | 1 | ||
| 25–29 | 55.8 | 0.96 | 0.95 | 0.89 – 1.01 | 28.9 | 1.03 | 1.04 | 0.93 – 1.17 | |
| 30–34 | 58.6 | 1.00 | 1.00 | 0.95 – 1.07 | 27.0 | 1.00 | 0.94 | 0.84 – 1.05 | |
| 35–39 | 60.0 | 1.03 | 1.05 | 0.99 – 1.11 | 25.2 | 1.01 | |||
| 40–44 | 62.0 | 1.06 | 24.3 | 1.00 | |||||
| 45–49 | 61.8 | 1.06 | 25.3 | ||||||
| 50–54 | 65.5 | 22.2 | |||||||
| 55–59 | 68.7 | 20.3 | |||||||
| 60–64 | 71.6 | 18.0 | |||||||
| 65–69 | 76.3 | 14.9 | |||||||
| 70–74 | 77.7 | 14.9 | |||||||
| 75–79 | 76.1 | 14.5 | |||||||
| 80+ | 76.5 | 16.3 | |||||||
| (N = 23058) | None | 68.5 | 1 | 1 | 20.4 | 1 | 1 | ||
| Less than 2 | 65.1 | 1.00 | 0.96 – 1.03 | 22.2 | 1.09 | 1.00 | 0.90 – 1.11 | ||
| 2–4 | 64.6 | 0.97 | 0.95 – 1.00 | 22.8 | 1.07 | 0.99 – 1.15 | |||
| 5 or more | 64.8 | 0.98 | 0.95 – 1.01 | 23.0 | 1.11 | 1.00 – 1.22 | |||
| Undergoing education or other | 67.8 | 20.5 | 1.00 | 0.94 | 0.81 – 1.08 | ||||
| (N = 24154) | 0–1 | 66.1 | 1 | 13 | 24.3 | 1 | 1 | ||
| 2–3 | 64.3 | 0.97 | 0.99 | 0.96 – 1.03 | 24.4 | 1.00 | 0.96 | 0.88 – 1.05 | |
| 4–5 | 65.1 | 0.98 | 1.01 | 0.97 – 1.04 | 22.5 | 0.93 | |||
| 6–7 | 65.7 | 0.99 | 1.04 | 1.00 – 1.08 | 21.2 | ||||
| 8–9 | 68.0 | 1.03 | 19.4 | ||||||
| 10+ | 68.2 | 1.03 | 18.7 | ||||||
| (N = 16168) | Less than 1 | 65.6 | 1 | 13 | 25.8 | 1 | 1 | ||
| 1–2 | 64.8 | 0.99 | 0.97 | 0.92 – 1.02 | 23.8 | 0.92 | 0.97 | 0.86 – 1.10 | |
| 3–7 | 65.6 | 1.00 | 0.96 | 0.92 – 1.01 | 21.9 | 0.92 | 0.82 – 1.04 | ||
| 8–12 | 68.1 | 1.04 | 0.98 | 0.93 – 1.03 | 20.2 | 0.89 | 0.78 – 1.01 | ||
| 13+ | 70.7 | 1.00 | 0.95 – 1.05 | 17.5 | |||||
| (N = 24154) | Excellent | 70.0 | 1 | 13 | 19.6 | 1 | 1 | ||
| Very good | 67.1 | 21.2 | 1.08 | ||||||
| Good | 66.3 | 21.8 | |||||||
| Fair | 61.1 | 25.3 | |||||||
| Poor | 60.8 | 25.1 | |||||||
| (N = 23810) | No | 64.9 | 1 | 13 | 23.4 | 1 | 1 | ||
| Yes-KRTC | 71.2 | 17.9 | |||||||
| Yes-other or multiple | 63.8 | 0.98 | 1.00 | 0.98 – 1.03 | 22.7 | 0.97 | 0.93 | 0.88 – 1.00 | |
| (N = 16049) | None | 64.9 | 1 | 13 | 23.4 | 1 | 1 | ||
| K – Cardiovascular | 66.3 | 19.8 | |||||||
| R – Respiratory | 73.8 | 1.02 | 1.02 | 0.97 – 1.07 | 16.0 | 0.95 | 0.96 | 0.85 – 1.09 | |
| T – Endocrine | 66.2 | 1.03 | 0.99 – 1.08 | 22.1 | 0.81 | 0.92 | 0.80 – 1.07 | ||
| C – Cancer | 70.5 | 18.8 | 0.56 | ||||||
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self-rated health and clustering of patients. Numbers in italics are used to indicate statistical significance.
1 Patients who marked 100% of the answered questions in one of the two most positive answering categories.
2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories.
3 Poisson regression with robust variance
Dimension 5: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the accessibility.
| (N = 25560) | Female | 29.1 | 1 | 1 | 34.0 | 1 | 1 | ||
| Male | 32.3 | 0.97 | 0.93 – 1.02 | 30.7 | 0.99 | 0.94 – 1.03 | |||
| (N = 25560) | 18–24 | 17.8 | 1 | 1 | 39.5 | 1 | 1 | ||
| 25–29 | 19.7 | 1.11 | 1.09 | 0.94 – 1.26 | 40.7 | 1.03 | 1.04 | 0.96 – 1.13 | |
| 30–34 | 21.0 | 39.4 | 1.00 | 0.98 | 0.90 – 1.07 | ||||
| 35–39 | 21.5 | 40.0 | 1.01 | 0.97 | 0.89 – 1.06 | ||||
| 40–44 | 23.6 | 39.5 | 1.00 | 0.93 | 0.85 – 1.02 | ||||
| 45–49 | 26.5 | 35.7 | |||||||
| 50–54 | 27.9 | 35.0 | |||||||
| 55–59 | 34.3 | 29.4 | |||||||
| 60–64 | 38.5 | 26.5 | |||||||
| 65–69 | 42.6 | 22.9 | |||||||
| 70–74 | 46.7 | 20.8 | |||||||
| 75–79 | 46.5 | 20.2 | |||||||
| 80+ | 45.7 | 22.4 | |||||||
| (N = 24385) | None | 32.6 | 1 | 1 | 31.7 | 1 | 1 | ||
| Less than 2 | 30.6 | 1.08 | 0.99 – 1.16 | 34.7 | 1.00 | 0.93 – 1.08 | |||
| 2–4 | 28.6 | 1.00 | 0.95 – 1.06 | 34.1 | 0.98 | 0.93 – 1.03 | |||
| 5 or more | 29.3 | 1.02 | 0.94 – 1.10 | 32.1 | 1.01 | 0.93 | 0.86 – 1.01 | ||
| Undergoing education or other | 32.2 | 28.8 | 0.91 | ||||||
| (N = 25560) | 0–1 | 28.3 | 1 | 1 | 35.9 | 1 | 1 | ||
| 2–3 | 26.9 | 0.95 | 0.99 | 0.92 – 1.07 | 37.0 | 1.03 | 1.00 | 0.94 – 1.06 | |
| 4–5 | 29.8 | 1.05 | 1.06 | 0.98 – 1.14 | 33.5 | ||||
| 6–7 | 31.4 | 30.0 | |||||||
| 8–9 | 33.9 | 28.5 | |||||||
| 10+ | 35.3 | 26.8 | |||||||
| (N = 17001) | Less than 1 | 24.6 | 1 | 1 | 36.8 | 1 | 1 | ||
| 1–2 | 25.9 | 1.05 | 0.99 | 0.87 – 1.12 | 36.1 | 0.98 | 1.03 | 0.94 – 1.12 | |
| 3–7 | 27.2 | 1.11 | 1.00 | 0.89 – 1.12 | 34.7 | 0.94 | 1.01 | 0.93 – 1.09 | |
| 8–12 | 31.8 | 1.12 | 0.98 – 1.28 | 31.6 | 0.95 | 0.86 – 1.05 | |||
| 13+ | 38.0 | 26.5 | |||||||
| (N = 25560) | Excellent | 30.6 | 1 | 1 | 30.1 | 1 | 1 | ||
| Very good | 28.6 | 0.93 | 33.6 | ||||||
| Good | 30.6 | 1.00 | 33.4 | ||||||
| Fair | 30.7 | 1.00 | 33.3 | ||||||
| Poor | 33.0 | 1.08 | 29.2 | 0.97 | |||||
| (N = 25197) | No | 27.6 | 1 | 1 | 35.2 | 1 | 1 | ||
| Yes-KRTC | 36.6 | 1.04 | 0.98 – 1.10 | 27.9 | 0.97 | 0.91 – 1.03 | |||
| Yes-other or multiple | 30.5 | 1.01 | 0.96 – 1.06 | 32.1 | 0.95 | 0.91 – 1.00 | |||
| (N = 17208) | None | 27.6 | 1 | 1 | 35.2 | 1 | 1 | ||
| K – Cardiovascular | 37.7 | 1.01 | 0.94 – 1.09 | 26.1 | 0.96 | 0.86 – 1.06 | |||
| R – Respiratory | 32.3 | 1.04 | 0.95 – 1.15 | 31.8 | 0.90 | 0.99 | 0.90 – 1.09 | ||
| T – Endocrine | 37.0 | 1.08 | 0.99 – 1.17 | 28.9 | 0.98 | 0.88 – 1.09 | |||
| C – Cancer | 42.7 | 22.3 | |||||||
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self-rated health and clustering of patients. Numbers in italics are used to indicate statistical significance.
1 Patients who marked 100% of the answered questions in one of the two most positive answering categories.
2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories.
3 Poisson regression with robust variance